D-0375-2025 Class II Ongoing

Recalled by Apipharma — Zagreb, N/A

FDA drug recall D-0375-2025 was initiated by Apipharma on Apr 9, 2025 and is designated Class II. Reason for recall: CGMP Deviations The recall status is ongoing. Affected quantity: 4,218 boxes.

Recall details

Product Type
Drugs
Report Date
Apr 30, 2025
Initiation Date
Apr 9, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,218 boxes

Product description

Hemopropin Ointment, Lanolin 17.76% and Petrolatum 71.2%, Net Wt. 0.7 oz (20g) tubes, Manufactured by: Apipharma d.o.o, Croatia, Distributed by: Apipharma, LLC, Tempe, AZ UPC 3 858882 103534 and UPC 3 858882 101318

Reason for recall

CGMP Deviations

Distribution pattern

AZ

Code information

Lot #: A00001, Exp.: 2027-12; A00005, Exp.: 2027-01; B00001, Exp.:2028-02

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0375-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0375-2025. Report a data issue: hello@regdatalab.com.